Bacil Pharma Ltd.
Snapshot View

7.40 0.00

05 December 2022, 04:00:00 PM
Volume: 500

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.bacilpharma.com
Market Cap 4.36 Cr.
Enterprise Value(EV) 4.39 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -6.35 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-09
Industry PE 35.38 Trailing Twelve Months Ending 2022-09
Book Value / Share 1.03 Trailing Twelve Months Ending 2022-09
Price to Book Value 7.21 Calculated using Price: 7.40
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.59 Cr. 5,890,000 Shares
FaceValue 10
Company Profile
Bacil Pharma was incorporated in the year 1987. Its plant is located at Lote-Parshuraram, an industrial area about 250 kilometer from Mumbai city.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
1 Week
-0.13%
1 Month
+5.87%
3 Month
+82.72%
6 Month
+27.37%
1 Year
+87.34%
2 Year
+32.14%
5 Year
+20.33%
10 Year
+124.24%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -1.84 -0.54 -1.23 -0.04 -101.39 -23.83 -31.16 -31.82 -575.48
Return on Capital Employed (%) -1.65 -0.48 -1.06 -0.03 -83.02 -16.18 -17.20 -15.05 -273.27
Return on Assets (%) -1.61 -0.48 -1.01 -0.03 -65.68 -7.53 -7.56 -6.06 -150.07

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 7 6 6 6 2 2 1 1 1 1
Non Curr. Liab. 0 0 0 0 0 0 0
Curr. Liab. 0 0 0 0 3 3 3 3 0 0
Minority Int.
Equity & Liab. 7 7 7 7 5 4 4 4 1 1
Non Curr. Assets 6 6 6 7 3 4 4 4 1 1
Curr. Assets 1 0 0 0 1 1 0 0 0 1
Misc. Exp. not W/O 1
Total Assets 7 7 7 7 5 4 4 4 1 1

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 0 0 0 0 0 0 0 0 0 0
Total Expenditure 0 0 0 0 0 0 0 0 -4 -4
PBIDT 0 0 0 0 0 0 0 -4 -4
Interest 0 0
Depreciation 0 0 0 0
Taxation
Exceptional Items -4
PAT 0 0 0 -4 0 0 0 -4 -4
Adjusted EPS 0 0 0 -6 -1 -1 0 -7 -6

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 0 1 0 0 0 -4
Cash Fr. Inv. 0 0 0 0 -1 0 0 1 4
Cash Fr. Finan. 0 0 0 0
Net Change 0 0 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 45.09 45.09 42.67 42.67 42.67 42.67 42.67 42.67 42.67
Public 54.91 54.91 57.33 57.33 57.33 57.33 57.33 57.33 57.33
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 08 Nov 2022
Non-Applicability Of Reg. 23(9) Of SEBI (LODR) Regulations For The Quarter And Half Year Ended 30Th September 2022
non-Applicability of Reg. 23(9) of SEBI (LODR) Regulations for the quarter and half year ended 30th september 2022
Thu, 03 Nov 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of extract of Newspaper clipping of un-audited Financial Results for the quarter and half year ended 30.09.2022
Wed, 02 Nov 2022
SUBMISSION OF UN-AUDITED QUARTERLY FINANCIALS FOR THE QUARTER ENDED 30.09.2022
SUBMISSION OF UN-AUDITED QUARTERLY FINANCIALS FOR THE QUARTER ENDED 30.09.2022

Technical Scans View Details >>

Mon, 05 Dec 2022
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Opening at Low Opening at Low
High Increase 1 Month High Increase 1 Month

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,386.88 1,039.40 -0.1%
Cipla Ltd. 90,016.94 1,115.35 +0.1%
Divi's Laboratories Ltd. 89,432.38 3,368.85 -0.4%
Dr. Reddy's Laboratories Ltd. 74,582.06 4,479.40 -0.7%
Apollo Hospitals Enterprise Ltd. 68,701.75 4,778.10 -1.9%
Torrent Pharmaceuticals Ltd. 54,598.02 1,613.20 -0.4%
Abbott India Ltd. 42,923.27 20,059.40 -0.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.65 1,039.40 -0.1%
Cipla Ltd. Consolidated 2022-09 35.09 1,115.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 29.88 3,368.85 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 23.99 4,479.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 81.83 4,778.10 -1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 68.50 1,613.20 -0.4%
Abbott India Ltd. Standalone 2022-09 48.68 20,059.40 -0.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.69 1,039.40 -0.1%
Cipla Ltd. Consolidated 2022-09 4.11 1,115.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.37 3,368.85 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.59 4,479.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.48 4,778.10 -1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 8.96 1,613.20 -0.4%
Abbott India Ltd. Standalone 2022-09 15.81 20,059.40 -0.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,039.40 -0.1%
Cipla Ltd. Consolidated 2022-03 0.04 1,115.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,368.85 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,479.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,778.10 -1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,613.20 -0.4%
Abbott India Ltd. Standalone 2022-03 0.00 20,059.40 -0.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,039.40 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,115.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,368.85 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,479.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,778.10 -1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,613.20 -0.4%
Abbott India Ltd. Standalone 2022-03 29.95 20,059.40 -0.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,039.40 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,115.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,368.85 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,479.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,778.10 -1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,613.20 -0.4%
Abbott India Ltd. Standalone 2022-03 29.95 20,059.40 -0.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,039.40 -0.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,115.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,368.85 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,479.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,778.10 -1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,613.20 -0.4%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,059.40 -0.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,039.40 -0.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,115.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,368.85 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,479.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,778.10 -1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,613.20 -0.4%
Abbott India Ltd. Standalone 2022-03 798.70 20,059.40 -0.6%

FAQ's On Bacil Pharma Ltd.

What is Bacil Pharma share price?

Can I buy Bacil Pharma shares now?

What is the Market Cap of Bacil Pharma?

What are the key metrics to analyse Bacil Pharma?

What is the 52 Week High and Low of Bacil Pharma?

What is the trend of Bacil Pharma share price?